Compare SenesTech, Inc. with Similar Stocks
Dashboard
1
Poor Management Efficiency with a low ROE of 0%
- The company has reported losses. Due to this company has reported negative ROE
2
Poor long term growth as Operating profit has grown by an annual rate 6.02% of over the last 5 years
3
With a growth in Operating Profit of 39.9%, the company declared Very Positive results in Sep 25
4
Risky -
5
Increasing Participation by Institutional Investors
6
Below par performance in long term as well as near term
Stock DNA
Chemicals & Petrochemicals
USD 10 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.88
-51.41%
0.87
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Dec 2025)
Net Profit:
-2 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-24.89%
0%
-24.89%
6 Months
-61.87%
0%
-61.87%
1 Year
-23.58%
0%
-23.58%
2 Years
-74.56%
0%
-74.56%
3 Years
19.86%
0%
19.86%
4 Years
-99.9%
0%
-99.9%
5 Years
-99.96%
0%
-99.96%
SenesTech, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
24.99%
EBIT Growth (5y)
6.02%
EBIT to Interest (avg)
-7.97
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.49
Sales to Capital Employed (avg)
0.39
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
15.73%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.87
EV to EBIT
0.01
EV to EBITDA
0.01
EV to Capital Employed
-0.05
EV to Sales
-0.03
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-51.41%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 2 Schemes (1.42%)
Foreign Institutions
Held by 3 Foreign Institutions (0.49%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
0.40
0.70
-42.86%
Operating Profit (PBDIT) excl Other Income
-1.80
-1.30
-38.46%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-1.80
-1.30
-38.46%
Operating Profit Margin (Excl OI)
-4,467.90%
-1,952.20%
-251.57%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is -42.86% vs 16.67% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is -38.46% vs 18.75% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
2.20
1.90
15.79%
Operating Profit (PBDIT) excl Other Income
-6.40
-6.10
-4.92%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-6.40
-6.20
-3.23%
Operating Profit Margin (Excl OI)
-2,928.90%
-3,365.10%
43.62%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 15.79% vs 58.33% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -3.23% vs 19.48% in Dec 2024
About SenesTech, Inc. 
SenesTech, Inc.
Chemicals & Petrochemicals
SenesTech, Inc. is a biotechnology company that has developed a technology for managing animal pest populations, initially rat populations, through fertility control. Its product ContraPest, is in the pest control industry in attacking the reproductive systems of both male and female rats. ContraPest targets the reproductive capabilities of rodents by inducing the gradual loss of eggs in female rodents and disruption of sperm in male rodents, resulting in contraception that can progress to sterility in both females and males. Its pipeline includes feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment. Its Feral animal fertility control has its application in the population management segment and targets feral dogs and hogs. Its Non-Surgical Spay and Neutering have its application in companion animal health, and targets companion dogs and cats. The Company's Boar taint has its application in food production and safety and targets boars.
Company Coordinates 
Company Details
3140 N Caden Ct Ste 1 , FLAGSTAFF AZ : 86004-9428
Registrar Details






